IBRX - ImmunityBio extends gains on surging volumes after regulatory update
2023-10-24 12:25:10 ET
More on ImmunityBio
- ImmunityBio: Ongoing Dilution And Regulatory Uncertainties Blur Investment Prospects
- ImmunityBio announces $470M equity and debt financing from founder Patrick Soon-Shiong and Nant Entities
- Seeking Alpha’s Quant Rating on ImmunityBio
- Historical earnings data for ImmunityBio
- Financial information for ImmunityBio
For further details see:
ImmunityBio extends gains on surging volumes after regulatory update